IMARC Group has recently released a new research study titled “South Korea Biotechnology Market Report by Product Type (Instruments, Reagents, Software and Services), Technology (Nanobiotechnology, Tissue Engineering and Regeneration, DNA Sequencing, Cell-Based Assays, Fermentation, PCR Technology, Chromatography, and Others), Application (Healthcare, Food and Agriculture, Natural Resources and Environment, Industrial Processing, Bioinformatics, and Others), and Region 2025-2033”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
South Korea Biotechnology Market Overview
The South Korea biotechnology market size reached USD 14.4 Billion in 2024 and is projected to grow to USD 24.1 Billion by 2033. The market is expected to grow at a CAGR of 5.9% during the forecast period from 2025 to 2033. Growth is driven by rising demand for biopharmaceuticals, precision medicine, and sustainable agricultural solutions in the region. The increasing utilization of biotechnology across healthcare, agriculture, and environmental management sectors propels a dynamic market landscape.
Study Assumption Years
- Base Year: 2024
- Historical Year/Period: 2019-2024
- Forecast Year/Period: 2025-2033
South Korea Biotechnology Market Key Takeaways
- Current Market Size: USD 14.4 Billion in 2024
- CAGR: 5.9% (2025-2033)
- Forecast Period: 2025-2033
- The market encompasses diverse biotechnology domains including genetic engineering, biopharmaceuticals, bioinformatics, and synthetic biology.
- Biotechnology in South Korea significantly contributes to developments in modern medicine, sustainable agriculture, and environmental management.
- The sector benefits from government and private R&D initiatives fostering innovation and enhancing the country’s global scientific standing.
- Key market segments analyzed include product type, technology, application, and regional markets.
- Comprehensive competitive landscape insights are offered, including company profiling and market structure analysis.
Sample Request Link: https://www.imarcgroup.com/south-korea-biotechnology-market/requestsample
Market Growth Factors
The South Korea biotechnology market is propelled by a surge in demand for biopharmaceuticals and precision medicines, which are revolutionizing healthcare treatments. Increasing adoption of advanced genetic engineering techniques enables tailored therapies, boosting the healthcare application segment. Simultaneously, sustainable agricultural practices driven by biotechnology help enhance crop yields and resilience, addressing food security and environmental challenges in the region.
Furthermore, biotechnology is extensively utilized in environmental management to combat pollution and conserve natural resources. South Korea leverages biotechnology innovations for sustainable solutions, which supports the market’s growing momentum. Government and private sectors actively invest in research and development activities, accelerating the creation of novel products and technologies that bolster industry competitiveness and future growth prospects.
The convergence of disciplines such as bioinformatics and synthetic biology fosters enhanced understanding and manipulation of biological systems. This stimulates the development of innovative healthcare solutions, sustainable agriculture practices, and advanced materials. These focused advancements, paired with growing regional adoption, fuel the South Korea biotechnology market’s strong growth trajectory during the forecast period.
Market Segmentation
#### Product Type Insights:
- Instruments
- Reagents
- Software and Services
Technology Insights:
- Nanobiotechnology
- Tissue Engineering and Regeneration
- DNA Sequencing
- Cell-Based Assays
- Fermentation
- PCR Technology
- Chromatography
- Others
Application Insights:
- Healthcare
- Food and Agriculture
- Natural Resources and Environment
- Industrial Processing
- Bioinformatics
- Others
Regional Insights:
- Seoul Capital Area
- Yeongnam (Southeastern Region)
- Honam (Southwestern Region)
- Hoseo (Central Region)
- Others
Ask For an Analyst- https://www.imarcgroup.com/request?type=report&id=21475&flag=C
Regional Insights
The Seoul Capital Area is identified as a dominant region in the South Korea biotechnology market. Specific statistics such as market share or CAGR by region are not provided in the source. This region benefits from concentrated R&D infrastructure and industry presence, supporting sustained growth and innovation in biotechnology.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302
